Explore breakthrough studies, CRISPR applications, and transformative discoveries in gene editing technology
Discover how bone marrow delivery of genetically modified CD34+ HSPCs improves homing and engraftment of short-term progenitors over long-term repopulating hematopoietic stem cells.